For years, the focus has been on expanding access to real-world data. Today, a different question is emerging: how do we ensure we have the right data to inform decisions with confidence? Our recent benchmark research suggests that as linked oncology data becomes more common, organizations are placing greater emphasis on data quality, completeness and confidence, not simply data volume. This McKesson article examines what oncology data leaders are seeing today and where the industry may be headed next. #RealWorldData #Oncology #LifeSciences #DataAnalytics
A new survey of 100 senior-level life sciences professionals highlights a shift in how the industry is thinking about oncology real-world data (RWD). The conversation is moving from data volume to data confidence, with growing emphasis on linked data that is trusted, timely and ready to support stronger clinical and commercial decisions. Read more about what the findings may signal for the future of oncology RWD: https://bit.ly/4xiItpQ